263 related articles for article (PubMed ID: 18620950)
1. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial.
Clarke SE; Jukes MC; Njagi JK; Khasakhala L; Cundill B; Otido J; Crudder C; Estambale BB; Brooker S
Lancet; 2008 Jul; 372(9633):127-138. PubMed ID: 18620950
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial.
Glinz D; Hurrell RF; Ouattara M; Zimmermann MB; Brittenham GM; Adiossan LG; Righetti AA; Seifert B; Diakité VG; Utzinger J; N'Goran EK; Wegmüller R
Malar J; 2015 Sep; 14():347. PubMed ID: 26377199
[TBL] [Abstract][Full Text] [Related]
4. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA
PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
Aponte JJ; Schellenberg D; Egan A; Breckenridge A; Carneiro I; Critchley J; Danquah I; Dodoo A; Kobbe R; Lell B; May J; Premji Z; Sanz S; Sevene E; Soulaymani-Becheikh R; Winstanley P; Adjei S; Anemana S; Chandramohan D; Issifou S; Mockenhaupt F; Owusu-Agyei S; Greenwood B; Grobusch MP; Kremsner PG; Macete E; Mshinda H; Newman RD; Slutsker L; Tanner M; Alonso P; Menendez C
Lancet; 2009 Oct; 374(9700):1533-42. PubMed ID: 19765816
[TBL] [Abstract][Full Text] [Related]
6. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
Shulman CE; Dorman EK; Cutts F; Kawuondo K; Bulmer JN; Peshu N; Marsh K
Lancet; 1999 Feb; 353(9153):632-6. PubMed ID: 10030329
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
8. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
[TBL] [Abstract][Full Text] [Related]
9. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Dicko A; Barry A; Dicko M; Diallo AI; Tembine I; Dicko Y; Dara N; Sidibe Y; Santara G; Conaré T; Chandramohan D; Cousens S; Milligan PJ; Diallo DA; Doumbo OK; Greenwood B
PLoS One; 2011; 6(8):e23390. PubMed ID: 21858096
[TBL] [Abstract][Full Text] [Related]
10. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Tine RC; Faye B; Ndour CT; Ndiaye JL; Ndiaye M; Bassene C; Magnussen P; Bygbjerg IC; Sylla K; Ndour JD; Gaye O
Malar J; 2011 Dec; 10():358. PubMed ID: 22166001
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
[TBL] [Abstract][Full Text] [Related]
12. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
Cissé B; Sokhna C; Boulanger D; Milet J; Bâ el H; Richardson K; Hallett R; Sutherland C; Simondon K; Simondon F; Alexander N; Gaye O; Targett G; Lines J; Greenwood B; Trape JF
Lancet; 2006 Feb; 367(9511):659-67. PubMed ID: 16503464
[TBL] [Abstract][Full Text] [Related]
13. Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
Liljander A; Chandramohan D; Kweku M; Olsson D; Montgomery SM; Greenwood B; Färnert A
PLoS One; 2010 Oct; 5(10):e13649. PubMed ID: 21048970
[TBL] [Abstract][Full Text] [Related]
14. Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.
Halliday KE; Okello G; Turner EL; Njagi K; Mcharo C; Kengo J; Allen E; Dubeck MM; Jukes MC; Brooker SJ
PLoS Med; 2014 Jan; 11(1):e1001594. PubMed ID: 24492859
[TBL] [Abstract][Full Text] [Related]
15. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
Staedke SG; Kamya MR; Dorsey G; Gasasira A; Ndeezi G; Charlebois ED; Rosenthal PJ
Lancet; 2001 Aug; 358(9279):368-74. PubMed ID: 11502317
[TBL] [Abstract][Full Text] [Related]
16. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
Kweku M; Liu D; Adjuik M; Binka F; Seidu M; Greenwood B; Chandramohan D
PLoS One; 2008; 3(12):e4000. PubMed ID: 19098989
[TBL] [Abstract][Full Text] [Related]
17. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
[TBL] [Abstract][Full Text] [Related]
18. Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
Rehman AM; Maiteki-Sebuguzi C; Gonahasa S; Okiring J; Kigozi SP; Chandler CIR; Drakeley C; Dorsey G; Kamya MR; Staedke SG
Malar J; 2019 Sep; 18(1):318. PubMed ID: 31533845
[TBL] [Abstract][Full Text] [Related]
19. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
[TBL] [Abstract][Full Text] [Related]
20. Intermittent preventive treatment with antimalarial drugs.
Billal DS; Hotomi M; Yamanaka N
Lancet; 2009 Jan; 373(9657):28-9; author reply 29. PubMed ID: 19121718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
